The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism

Different miR-21-3p isoforms and their different features in colorectal cancer

(2017) Weijuan Jiao et al.   INTERNATIONAL JOURNAL OF CANCER

MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells

(2017) Viviana Costa et al.   Oncotarget

H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells

(2017) Shanwen Chen et al.   NEOPLASIA

MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6

(2016) Chengcao Sun et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-187-3p inhibits the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by targeting S100A4

(2016) Changwei Dou et al.   CANCER LETTERS

miR-483-5p promotes growth, invasion and self-renewal of gastric cancer stem cells by Wnt/β-catenin signaling

(2016) Kai Wu et al.   Molecular Medicine Reports

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma

(2016) Laura Lupini et al.   Oncotarget

miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2

(2016) Yan-Wu Zhou et al.   Oncotarget

Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells

(2016) Perla M. Báez-Vega et al.   Oncotarget

IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer

(2016) Hengmi Cui et al.   Oncotarget

HMGA1-pseudogenes and cancer

(2016) Marco De Martino et al.   Oncotarget

HMGA1P7-pseudogene regulates H19 and Igf2 expression by a competitive endogenous RNA mechanism

(2016) Marco De Martino et al.   Scientific Reports

HMGA1-pseudogene expression is induced in human pituitary tumors

(2015) Francesco Esposito et al.   CELL CYCLE

miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer

(2015) Haiyan Li et al.   Oncotarget

Pseudogene-derived lncRNAs: emerging regulators of gene expression

(2015) Michael J. Milligan et al.   Frontiers in Genetics

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs

(2015) Francesco Esposito et al.   Oncotarget

miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM

(2014) Q. Song et al.   CANCER RESEARCH

HMGA1-pseudogene overexpression contributes to cancer progression

(2014) Francesco Esposito et al.   CELL CYCLE

Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype

(2014) A. Federico et al.   Biology Open

Evolutionary conservation of long non-coding RNAs; sequence, structure, function

(2013) Per Johnsson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

(2013) O Chabre et al.   ENDOCRINE-RELATED CANCER

The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis

(2013) M. Liu et al.   GENES & DEVELOPMENT

PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis

(2011) Dario Palmieri et al.   ENDOCRINE-RELATED CANCER

A transcribed pseudogene of MYLK promotes cell proliferation

(2011) Yoo Jeong Han et al.   FASEB JOURNAL

HMGA and Cancer

(2010) Monica Fedele et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Oncogenic Role of miR-483-3p at the IGF2/483 Locus

(2010) A. Veronese et al.   CANCER RESEARCH

Target mRNA abundance dilutes microRNA and siRNA activity

(2010) Aaron Arvey et al.   Molecular Systems Biology

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

(2010) Laura Poliseno et al.   NATURE

Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes

(2010) Eusebio Chiefari et al.   Nature Communications

miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer

(2009) P. S. H. Soon et al.   CLINICAL CANCER RESEARCH

Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target

(2009) A. Bier et al.   MOLECULAR CANCER THERAPEUTICS

Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes

(2008) Toshiaki Watanabe et al.   NATURE